Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Elmer 2017 US Patent

From Bioblast
The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.
Publications in the MiPMap
Elmer E, Hansson MJ, Ehinger JK, Piel S, Moss S (2017) Succinate prodrugs for use in the treatment of lactic acidosis or drug-induced side-effects due to complex I-related impairment of mitochondrial oxidative phosphorylation. US Patent US20170100359 A1.

Β» Open Access

Elmer E, Hansson MJ, Ehinger JK, Piel S, Moss S (2017) US Patent

Abstract: The present invention relates to a succinate prodrug for use in the treatment or prevention of lactic acidosis.

β€’ Bioblast editor: Kandolf G β€’ O2k-Network Lab: SE Lund Elmer E


Labels: MiParea: Respiration, Pharmacology;toxicology 


Organism: Human  Tissue;cell: Heart, Blood cells, Fibroblast, Macrophage-derived, Platelet  Preparation: Intact cells 


Coupling state: LEAK, ROUTINE, OXPHOS, ET  Pathway: S, ROX  HRR: Oxygraph-2k 

Labels, PBMCs